Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 October 2020 | Story Lacea Loader

The Free State is currently one of the provinces in the country with the highest percentage of new tests that turn out positive for COVID-19. This also impacts on the staff and students at the University of the Free State (UFS), as the number of positive cases on the campuses has increased considerably during the past few weeks.  

The UFS experienced an increase of 47% in the number of students who tested positive from Level 2 of the national lockdown to Level 1. During the past few days, an increase of 21% in positive student cases has been experienced. In the case of staff, an increase of 34% in the number who tested positive occurred from Level 2 of the national lockdown to Level 1. Over  the past few days, an increase of 11% in positive cases has been experienced.

1. Adherence to national protocols and regulations

The safety, health, and well-being of staff and students remain a priority. Therefore, the university management is concerned about the rise in positive cases on the campuses and appeals to staff to adhere to the national protocols and regulations issued by the Ministers of Cooperative Governance and Traditional Affairs, Employment and Labour, Higher Education, Science and Innovation, and Health.   

It is important to note that non-adherence to certain of the national protocols and regulations is a criminal offence and is punishable by a fine or imprisonment of up to six months. By not adhering to national protocols and regulations, our staff is not only putting their own health at risk, but also the health of others.

2. Behaviour observed on campus  

The following behaviour has been observed among staff working on campus:
- Not adhering to social/physical distancing of 2 metres;
- Face-to-face contact without wearing masks (e.g. in boardrooms and tearooms, visiting each other in offices, etc);
- Not wearing a mask while moving on campus, as well as in buildings (except in the privacy of offices);
- Dishonesty during the screening process; and
- Non-compliance with isolation and quarantine guidelines.
Staff members are reminded that they may face disciplinary action if they do not adhere to the national COVID-19 protocols and regulations as issued by the different ministers. It is important that staff members be honest at all times during the screening process, as it has been observed that some staff members display some COVID-19-related symptoms but answer in the negative on the online screening app.

3. Reporting of positive COVID-19 cases
In terms of the directives issued by the Minister of Employment and Labour, the Minister of Health, and the Minister of Higher Education, Science and Innovation, the UFS is required to report all COVID-19 positive cases to the Department of Labour, the Department of Health, and the Department of Higher Education and Training.  All COVID-19 positive cases must thus be reported directly to the Senior Director: Human Resources (vjaarsj@ufs.ac.za) and Kovsie Health (johnr@ufs.ac.za) for further handling and reporting to the relevant government departments.

Please do not come to the campuses if you are experiencing any COVID-19-related symptoms and get tested as soon as possible.

Those staff members who test positive will receive the necessary advice from their medical practitioners and they can also contact Kovsie Health for assistance.


News Archive

Science is diversifying the uses of traditional medicines
2017-07-17

Description: Dr Motlalepula Matsabisa  Tags: traditional medicines, Indigenous Knowledge Systems, Dr Motlalepula Matsabisa, Malaria, priority disease  

Dr Motlalepula Matsabisa.
Photo: Anja Aucamp

According to the World Health Organisation, a large majority of the African population are making use of traditional medicines for health, socio-cultural, and economic purposes. In Africa, up to 80% of the population uses traditional medicines for primary healthcare.

The Indigenous Knowledge Systems (IKS) was identified as a lead programme under the directorship of Dr Motlalepula Matsabisa. Research undertaken by the IKS Lead Programme focuses on some key priority diseases of the country and region – including malaria, HIV, cancer, and diabetes.
 
Not just a plant or tree

Malaria is a priority disease and is prevalent in rural and poor areas, resulting in many traditional health practitioners claiming to treat and cure the disease. There may well be substance to these claims, since as much as 30% of the most effective current prescription medicines are derived from plants.  For instance, chloroquine, artemisinin for malaria, Metformin for diabetes, Vincristine and Vinblastine for cancer, are plant-derived drugs.  

Dr Matsabisa’s current research is investigating a South African medicinal plant that has been shown to have in vitro antiplasmodial activity, with subsequent isolation and characterisation of novel non-symmetrical sesquiterpene lactone compounds offering antimalarial activity. These novel compounds are now patented in South Africa and worldwide. This research is part of the UFS and South Africa’s strive to contribute to the regional and continental malaria problem. The UFS are thus far the only university that has been granted a permit by the Medicines Control Council to undertake research on cannabis and its potential health benefits.

“All of these projects are aimed
at adding value through the scientific
research of medicinal plants, which
can be used for treating illnesses,
diseases, and ailments.”

Recognition well deservedThrough Dr Matsabisa’s research input and contributions to the development of the pharmacology of traditional medicines, he recently became the first recipient of the International Prof Tuhinadrin Sen Award from the International Society of Ethnopharmacology (ISE) and the Society of Ethnopharmacology in India. ISE recognises outstanding contributions by researchers, scientists, and technologists in the area of medicinal plant research and ethnopharmacology internationally.

More recently, Dr Matsabisa undertook research projects funded by the National Research Foundation, as well as the Department of Science and Technology, on cancer, gangrene, and diabetes. He is also involved in a community project to develop indigenous teas with the community. He says, “All of these projects are aimed at adding value through the scientific research of medicinal plants, which can be used for treating illnesses, diseases, and ailments”.

Dr Matsabisa has worked with many local and international scientists on a number of research endeavours. He is grateful to his colleagues from the Department of Pharmacology in the Faculty of Health Sciences, who are dedicated to science research and the research of traditional medicines. The IKS unit also received immense support from the Directorate of Research Development.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept